Activation of the NF-κB/ALDH1A1 signaling promotes non-mutational resistance to EGFR-TKIs in non-small cell lung cancer
The NF-κB/ALDH1A1 signaling is established as a key non-genetic mechanism of acquired EGFR-TKI resistance and a rational combination strategy to overcome it is provided.